Augmentation of cadmium-induced oxidative cytotoxicity by pioglitazone in renal tubular epithelial cells

Toxicol Ind Health. 2019 Aug;35(8):530-536. doi: 10.1177/0748233719869548.

Abstract

The aim of this study was to examine whether a peroxisome proliferator-activated receptor (PPAR)-γ agonist could affect cadmium (Cd)-induced cytotoxicity via the increased expression of megalin, one of the uptake pathways, using renal epithelial LLC-PK1 cells. The treatment with 1 µM Cd for 24 h was not cytotoxic; however, when the cells were pretreated with 0.1 µM pioglitazone for 12 h and then exposed to 1 µM Cd for 24 h, significant accumulation of Cd and cytotoxicity were detected, with an increase in megalin mRNA expression. In addition, pretreatment with pioglitazone significantly increased the Cd-induced generation of hydrogen peroxide and cell apoptosis. The augmented Cd-induced cytotoxicity and apoptosis on preincubation with pioglitazone were inhibited by prior treatment with GW 9662 (PPAR-γ antagonist). These findings suggest that a PPAR-γ agonist could augment Cd-induced oxidative injury and cell apoptosis, possibly dependent on the expression level of the uptake pathway.

Keywords: LLC-PK cell; accumulation; cadmium; cytotoxicity; oxidative stress; pioglitazone.

MeSH terms

  • Animals
  • Cadmium / metabolism
  • Cadmium / toxicity*
  • Drug Synergism
  • Hydrogen Peroxide / metabolism
  • L-Lactate Dehydrogenase / metabolism
  • LLC-PK1 Cells / drug effects*
  • Oxidative Stress / drug effects*
  • Pioglitazone / toxicity*
  • Real-Time Polymerase Chain Reaction
  • Swine

Substances

  • Cadmium
  • Hydrogen Peroxide
  • L-Lactate Dehydrogenase
  • Pioglitazone